Skip to content

Mechanistic Investigation into the Regulatory Role of the METTL3/YTHDF1-m6A Axis on Microglial Glycolysis in Postherpetic Neuralgia

Mechanistic Investigation into the Regulatory Role of the METTL3/YTHDF1-m6A Axis on Microglial Glycolysis in Postherpetic Neuralgia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600131428
Enrollment
Unknown
Registered
2026-09-02
Start date
2026-09-15
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia(PHN)

Interventions

Sponsors

Zigong First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 90 eligible subjects aged 18-75 were divided into 3 groups, with 30 subjects in each group; 1. PHN(Postherpetic neuralgia) Group: Pain persists for more than 1 month after healing of the shingles rash, with a VAS score of >=4 points; 2. Acute Herpes Zoster(AHZ) Group: Patients with a clear history of herpes zoster, where the rash has not completely healed within 1 month of onset (e.g., during the crusting or erythematous phase). 3. Healthy Control Group (HC): Healthy volunteers matched for age and gender;

Exclusion criteria

Exclusion criteria: 1.Combine individuals with severe hematological diseases, autoimmune diseases, malignant tumors, and long-term users of immunosuppressants; 2.Severe infections, major surgeries, or blood transfusion history within the past 1 month; 3.Pregnant and lactating women. 4.Those with abnormal coagulation function or severe anemia who are unable to have venous blood drawn; 5.Individuals with mental disorders who are unable to understand and sign informed consent on their own and have no legal representative to accompany them; 6.Reject blood specimen outsourcing for third-party testing.

Design outcomes

Primary

MeasureTime frame
Gene expression;

Secondary

MeasureTime frame
Protein expression;Pain score;Pain sensitivity of animals after modeling;Overall m6A modification and glycolysis level of spinal cord tissue in model animals;

Countries

China

Contacts

Public ContactLiu Qian

Zigong First People's Hospital

liuqianzigong@163.com+86 813 2121126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026